AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
FDA okays generic Mircette; company to launch it under Kariva trademark.(Brief Article)
2002 MAY 9 - (NewsRx.com & NewsRx.net) -- Barr Laboratories, Inc., (BRL) announced that the U.S. Food & Drug Administration (FDA) has granted final approval for its application to manufacture and market a generic version of Organon, Inc.'s, Mircette oral contraceptive.
This product was a subject of a patent challenge initiated in September 2000. The company expects to be the first to market generic Mircette and is launching the product immediately. The company plans to market the product as a branded generic using the Kariva trademark.
Mircette is a 28-tablet regimen that represents a combination of desogestrel/ethinyl estradiol and ethinyl estradiol.
"The launch of the Kariva oral contraceptive product, combined with the company's existing generic oral contraceptive product line that includes Apri, Aviane, Lessina, and ...
- FDA okays generic Mircette; company to launch it under Kariva trademark.
- Newspaper article from: Biotech Week May 8, 2002 700+ words
...s, Mircette oral contraceptive. This product...generic using the Kariva trademark. Mircette is a...launch of the Kariva oral contraceptive product, combined...existing generic oral contraceptive product line that...
- An Essential Report on China's Oral Contraceptive Drugs Industry.
- Press release article from: M2 Presswire July 28, 2009 700+ words
...Essential Report on China's Oral Contraceptive Drugs Industry(C)1994-2009...of the "Report on China's Oral Contraceptive Drugs Industry" report to their offering. The oral contraceptive drug has two major components...
- BIOSANTE PHARMA ANNOUNCES ORAL CONTRACEPTIVE PHASE II STUDY.(Clinical report)
- News wire article from: AsiaPulse News June 20, 2007 700+ words
...BioSante Pharmaceuticals Announces Oral Contraceptive Phase II Study Initiation LINCOLNSHIRE...human clinical trial of a new oral contraceptive. BioSante will co-fund the development of the oral contraceptive up to $1.0 million. Pantarhei...
- Obesity and Oral Contraceptive Efficacy.
- Newspaper article from: Emergency Medicine Reports August 1, 2009 700+ words
Obesity and Oral Contraceptive Efficacy Abstract & Commentary...small effect of obesity on oral contraceptive efficacy but this finding was...question -- does obesity affect oral contraceptive efficacy? Nevertheless, should...
- BioSante Pharmaceuticals Announces Oral Contraceptive Phase II Study...
- Press release article from: Business Wire June 19, 2007 700+ words
...human clinical trial of a new oral contraceptive. BioSante will co-fund the development of the oral contraceptive up to $1.0 million. Pantarhei...the effect of a new patented oral contraceptive on sexual arousability and the...
- Oral Contraceptive Use and Risk of Gestational Trophoblastic Tumors.
- Magazine article from: OB/GYN Clinical Alert July 1, 1999 700+ words
Oral Contraceptive Use and Risk of Gestational Trophoblastic...Commentary Synopsis: Long duration of oral contraceptive use before conception increases...the incidence attributable to oral contraceptive use is low. Source: Palmer JR...
- ORTHO EXPANDS ITS ORAL CONTRACEPTIVE LINE: INTRODUCES ORTHO-CEPT AND BRINGS...
- Press release article from: PR Newswire December 15, 1992 700+ words
...desogestrel/ethinyl estradiol). The new oral contraceptive received market clearance from the...Administration yesterday. The new oral contraceptive, which contains the progestin desogestrel...become the most widely prescribed oral contraceptive since its European introduction in...
- Study finds no link to oral contraceptive use for women 35 and over.(breast...
- Magazine article from: Women's Health Weekly August 1, 2002 700+ words
...cancer risk among past or present oral contraceptive users in this age group." The researchers...women who had used any type of oral contraceptive did not have a greater risk of developing...examination of multiple aspects of oral contraceptive exposure (ever, current, or former...